ACME Laboratories Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares ACME Laboratories Ltd with three other companies in this sector in BANGLADESH : Renata Limited (2020 sales of 24.67 billion Bangladeshi Taka [US$289.93 million] ), Orion Pharma Ltd (7.65 billion Bangladeshi Taka [US$89.86 million] of which 70% was Power), and Beximco Pharmaceuticals Limited (25.61 billion Bangladeshi Taka [US$300.94 million] ).

Sales Analysis. During the third fiscal quarter of 2021, sales at ACME Laboratories Ltd totalled 5.23 billion Bangladeshi Taka. This is an increase of 9.8% from the 4.77 billion Bangladeshi Taka in sales at the company during the third quarter of 2020. During the first three quarters of 2021, sales totalled 15.23 billion Bangladeshi Taka, which is 9.6% higher than through the first three fiscal quarters of 2020. During the previous 19 quarters, sales at ACME Laboratories Ltd have increased compared with the same quarter in the previous year. Sales at ACME Laboratories Ltd appear to have some seasonality: during each of the previous 5 fiscal years, sales have been highest during the fourth quarter, which has accounted for between 26.2% and 28.4% of the annual fiscal year sales. ACME Laboratories Ltd reported sales of 19.00 billion Bangladeshi Taka (US$223.29 million) for the fiscal year ending June of 2020. This represents an increase of 16.5% versus 2019, when the company's sales were 16.31 billion Bangladeshi Taka. Sales at ACME Laboratories Ltd have increased during each of the previous five years (and since 2015, sales have increased a total of 65%).